122 results
D
PRTG
Portage Biotech Inc
13 Oct 23
$1.00 in options / securities to be acquired, sold $1.00, 1 investor
6:03pm
that is the subject of this Form D, States cannot
routinely require offering materials under this undertaking or otherwise and can require offering … materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
6-K
EX-10.1
PRTG
Portage Biotech Inc
3 Oct 23
Current report (foreign)
4:05pm
(or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto … or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials
6-K
EX-99.1
PRTG
Portage Biotech Inc
8 Sep 23
Current report (foreign)
4:01pm
jurisdiction. Such an offer can only be made by prospectus or other authorized offering document. This presentation and materials or fact
6-K
EX-99.1
PRTG
Portage Biotech Inc
14 Aug 23
Current report (foreign)
4:52pm
jurisdiction . Such an offer can only be made by prospectus or other authorized offering document . This presentation and materials or fact
6-K
EX-99.1
q5lprye
20 Jun 23
Current report (foreign)
5:53pm
6-K
EX-99.1
dije mru1mz
1 May 23
Current report (foreign)
8:00am
6-K
EX-99.1
runx g1iyhww
30 Nov 22
Current report (foreign)
9:08pm
6-K
5u1qe4koqt8 1e1o
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.1
z9p12uf5
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.1
yp70 9ke57nq34ydu80
14 Sep 22
Current report (foreign)
10:31am
D
3ckg 4ptn
29 Jul 22
$34.64M in equity, sold $34.64M, 4 investors
6:15pm
6-K
EX-2.1
a87t7
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-10.3
w2hz8 0rft
8 Jul 22
Current report (foreign)
8:58am